Empagliflozin Coupon - Empagliflozin 25mg tablet


Jardiance is used to control blood sugar and treat type 2 diabetes. It can also reduce the risk of heart attack or stroke if you have type 2 diabetes and risk factors for heart disease. Jardiance is more popular than other SGLT2 inhibitors. There are currently no generic alternatives to Jardiance.

Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Jardiance is covered by some Medicare and insurance plans.

Empagliflozin Coupon - Empagliflozin 25mg tablet

Savings Alert: We've added new, lower prices at most pharmacies for this prescription. Learn More

Empagliflozin Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Warns of Serious Genital Infection Linked to SGLT2 Inhibitors for Diabetes

Roni Shye - September 14, 2018

Just last week, the Food and Drug Administration (FDA) released a new warning for SGLT2 inhibitors, a class of drugs used to lower blood sugar in adults with type 2 diabetes. According to the FDA, a serious bacterial infection known as necrotizing fasciitis has been reported in the genital area of some patients taking SGLT2 inhibitors. While this condition is rare and only 12 cases have been confirmed since 2013, necrotizing fasciitis spreads rapidly and can be deadly. See More

The FDA is Currently Reviewing the First Oral Medication for Type 1 Diabetes

Roni Shye - August 21, 2018

After decades of little innovation in treatments for type 1 diabetes, the FDA is on track to approve Zynquista, the first oral antidiabetic drug in the US for adults with type 1 diabetes, by March 2019.

Current type 1 diabetes medications

At present, those with type 1 diabetes, also known as juvenile or insulin-dependent diabetes, use injectable or inhaled insulins to survive. Sometimes, they also use Symlin, an injectable non-insulin drug that makes patients feel full at meals, slows the rate at which food moves from the stomach into the small intestine, and stops the release of glucagon, a hormone that tells the liver to release sugar into the bloodstream. See More

Prescription Drug Coupons: How to Use Pharmacy Discounts & Manufacturer Savings Cards

Roni Shye - August 10, 2018

You’re ready to pick up your prescription at the pharmacy. But how expensive will it be? And is there anything you can do to save money? Let’s discuss how to use pharmacy discount coupons and manufacturer savings cards to help you save on the medications you need.

First, what’s the difference between pharmacy discount coupons and manufacturer savings cards?

Pharmacy discount coupons

Pharmacy discount coupons, like the ones you’ll find on GoodRx. See More

Generic Jardiance Is 5 Years Away (At Least) — Here Are 5 Ways To Save Now

Tori Marsh - August 02, 2018

Well-known for treating type 2 diabetes, Jardiance can also reduce the risk of a cardiovascular event by 38%—but it’s expensive. A 30-day supply costs well over $500, and many insurance plans won’t cover it. Luckily, there are ways for you to save as much as 100% off the cash price.

How much does Jardiance cost?

As of August 2018, the cash price for Jardiance is over $500 for 30 tablets. GoodRx discounts can help reduce this price a bit—to around $450—but that’s still way too much for most people. See More

New Recommendations for All Type 2 Diabetics

Dr. Sharon Orrange - January 16, 2018

Just recently, the American Diabetes Association updated their guidelines to include the recommendation that certain Type 2 Diabetics add to their regimen one of two medications shown to lower the risk of death from stroke and heart disease. Here is the update:

If you are a type 2 diabetic with established heart disease, aka atherosclerotic cardiovascular disease, and your target blood sugars aren’t being met with metformin and diet/exercise add Victoza injections 0r Jardiance. See More

80+ Drugs to Be Dropped By Insurance in 2018

Elizabeth Davis - August 22, 2017

If you’ve got health insurance, now’s a good time to be paying attention. Each year, prescription coverage – the “formulary” – changes, and yours will likely be changing in 2018.

Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing more than 80 prescription medications from their formularies at the end of 2017. See More

Updated FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye - June 21, 2017

On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review.

This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More

The 10 Worst Medications for Your Kidneys

Dr. Sharon Orrange - November 09, 2016

Did you know that there are certain medications out there that can cause forms of kidney damage? Don’t get me wrong, these medications can be life-altering, and even life-saving – but they are known to directly affect kidney function.

Medications that can damage the kidneys are known as “nephrotoxic medications.” These drugs can cause direct toxicity to the kidneys, and have been implicated in up to 25% of acute kidney injuries. See More

Jardiance for Diabetes Reduces Deaths from Heart Disease

Elizabeth Davis - September 17, 2015

Good news! In a just-published study, Jardiance (empagliflozin) for type 2 diabetes has been shown to reduce deaths from cardiovascular disease.

The results are impressive. Comparing Jardiance to a placebo, the study showed a 38% reduction in the risk of death from a cardiovascular cause (3.7% with Jardiance vs 5.9% with placebo). Jardiance was also shown to reduce the risk of any cardiovascular event (heart attack, stroke, or death) by 14%, and to reduce the risk of death from all causes by 32%. See More

Synjardy: Newly Approved for Type 2 Diabetes

Roni Shye - September 02, 2015

According to the 2014 National Diabetes Statistics Report from the CDC, 29.1 million people or 9.3% of the United States population has either type 1 or type 2 diabetes. That means that almost 1 in 11 Americans have diabetes!

With so many people affected, new medications are constantly being developed—especially to help treat type 2 diabetes, the most common form.

Synjardy (empagliflozin/metformin) is the newest of these drugs to receive FDA approval for the treatment of type 2 diabetes, on August 27, 2015. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy